Teleport Microcatheter

FDA-Cleared Indications

• To facilitate the placement and exchange of guidewires during percutaneous coronary intervention.
• For use in the coronary vasculature when additional guidewire support or access is needed.
• For use by trained physicians during catheter-based coronary procedures.

Clinical Applications

• Guidewire support during percutaneous coronary intervention.
• Guidewire exchange during coronary catheterization.
• Navigation through tortuous or otherwise challenging coronary anatomy.
• Support during treatment of difficult coronary lesions, including chronic total occlusions, when consistent with the device labeling and procedural plan.

Reported off-label uses

• Use in selected peripheral vascular interventions as a general-purpose support or exchange microcatheter.
• Delivery or exchange of devices in noncoronary vessels.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

• The available catheter sizes and configurations should be matched to the target vessel, guide catheter, guidewire, and planned intervention.
• Use is performed under fluoroscopic imaging, generally through arterial access such as the radial or femoral artery, with local anesthesia and possible moderate sedation.
• The catheter is intended to work with compatible guidewires and interventional equipment; users should verify compatibility before the procedure.
• Potential complications include vessel injury, dissection, perforation, spasm, thrombosis, embolization, bleeding, infection, and contrast-related adverse events.
• MRI safety depends on the exact device configuration and manufacturer labeling. The device should not be considered MRI safe or MRI conditional without confirming the current instructions for use.